These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 28733182)

  • 1. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
    Yohannes AM; Müllerová H; Hanania NA; Lavoie K; Tal-Singer R; Vestbo J; Rennard SI; Wouters EF
    Chest; 2016 Apr; 149(4):916-26. PubMed ID: 26836938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
    Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
    Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort.
    Meeraus WH; Mullerova H; El Baou C; Fahey M; Hessel EM; Fahy WA
    Int J Chron Obstruct Pulmon Dis; 2021; 16():225-244. PubMed ID: 33574663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations.
    Papaioannou AI; Bartziokas K; Tsikrika S; Karakontaki F; Kastanakis E; Banya W; Haniotou A; Papiris S; Loukides S; Polychronopoulos V; Kostikas K
    Eur Respir J; 2013 Apr; 41(4):815-23. PubMed ID: 22878874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
    Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients.
    Erdal M; Johannessen A; Eagan TM; Bakke P; Gulsvik A; Grønseth R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2099-108. PubMed ID: 27621614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.
    Rothnie KJ; Müllerová H; Smeeth L; Quint JK
    Am J Respir Crit Care Med; 2018 Aug; 198(4):464-471. PubMed ID: 29474094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.
    Borrell E; Rodríguez M; Torán P; Muñoz L; Pera G; Montellà N; Monteagudo M; Urrea M; Puigfel Y; Negrete A; Mezquiriz X; Domènech C; Lacasta A; García ML; Maneus S; Tintoré G
    BMC Public Health; 2009 Jan; 9():8. PubMed ID: 19134205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
    Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study.
    Fleehart S; Fan VS; Nguyen HQ; Lee J; Kohen R; Herting JR; Matute-Bello G; Adams SG; Pagalilauan G; Borson S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1321-9. PubMed ID: 25587219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort.
    Müllerova H; Maselli DJ; Locantore N; Vestbo J; Hurst JR; Wedzicha JA; Bakke P; Agusti A; Anzueto A
    Chest; 2015 Apr; 147(4):999-1007. PubMed ID: 25356881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire.
    Takada K; Matsumoto S; Kojima E; Iwata S; Okachi S; Ninomiya K; Morioka H; Tanaka K; Enomoto Y
    Respir Med; 2011 Oct; 105(10):1531-6. PubMed ID: 21454063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.
    Wetherbee EE; Niewoehner DE; Sisson JH; Lindberg SM; Connett JE; Kunisaki KM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1363-70. PubMed ID: 26229455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
    Adibi A; Sin DD; Safari A; Johnson KM; Aaron SD; FitzGerald JM; Sadatsafavi M
    Lancet Respir Med; 2020 Oct; 8(10):1013-1021. PubMed ID: 32178776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.